Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Hematological Oncology"
DOI: 10.1002/hon.3027
Abstract: Serum soluble CD23 (sCD23) levels have been acknowledged as a prognostic factor in patients with chronic lymphocytic leukemia (CLL), but their potential relevance has not been analyzed in recent times. We retrospectively studied 338 CLL,… read more here.
Keywords: lymphocytic leukemia; serum soluble; chronic lymphocytic; cd23 ... See more keywords